A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

Clinical trial NCT02860780 · COMPLETED

Trial details

NCT number: NCT02860780
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Metastatic Cancer Colorectal Cancer Non-small Cell Lung Cancer

Start date: 2016-08-10
Primary completion: 2017-05-15
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.